biotech deals

Genmab open to more M&A if it makes 'strategic sense,’ CFO says

Anthony Pagano sat down with Fierce at the Jefferies conference to talk M&A, asset ownership and whether the company will become an autoimmune player.

James Waldron Nov 21, 2024 1:05pm

Biophama VC, deal values and exits all rise in Q3: Pitchbook

Nov 20, 2024 6:15am

Novartis taps Ratio for $745M radiopharmaceutical pact

Nov 18, 2024 8:00am

Entero and ADC-like biotech Journey pen reverse merger

Nov 13, 2024 10:40am

Novartis pays Schrödinger $150M to form drug discovery pact

Nov 12, 2024 8:55am

Roche sparks $1.8B-plus discovery deal with Flare Therapeutics

Nov 12, 2024 7:00am